Steward Partners Investment Advisory LLC Sells 2,033 Shares of Colgate-Palmolive (NYSE:CL)

Steward Partners Investment Advisory LLC cut its position in shares of Colgate-Palmolive (NYSE:CL) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 72,827 shares of the company’s stock after selling 2,033 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Colgate-Palmolive were worth $6,621,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of CL. Schechter Investment Advisors LLC boosted its stake in Colgate-Palmolive by 6.0% during the fourth quarter. Schechter Investment Advisors LLC now owns 2,811 shares of the company’s stock worth $256,000 after buying an additional 158 shares in the last quarter. Meridian Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 9.5% in the 4th quarter. Meridian Wealth Management LLC now owns 11,953 shares of the company’s stock valued at $1,087,000 after purchasing an additional 1,040 shares in the last quarter. Fidelis Capital Partners LLC grew its holdings in shares of Colgate-Palmolive by 9.8% in the 4th quarter. Fidelis Capital Partners LLC now owns 15,171 shares of the company’s stock worth $1,320,000 after purchasing an additional 1,359 shares during the last quarter. LGT Fund Management Co Ltd. grew its holdings in shares of Colgate-Palmolive by 294.8% in the 4th quarter. LGT Fund Management Co Ltd. now owns 41,756 shares of the company’s stock worth $3,796,000 after purchasing an additional 31,179 shares during the last quarter. Finally, DJE Kapital AG acquired a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $101,597,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Shares of CL opened at $91.87 on Thursday. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The stock has a market cap of $74.56 billion, a P/E ratio of 26.10, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44. The stock’s 50-day moving average price is $88.72 and its two-hundred day moving average price is $95.27. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business posted $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Analysts Set New Price Targets

CL has been the topic of several research analyst reports. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. JPMorgan Chase & Co. cut their price objective on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. UBS Group decreased their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. Finally, StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a report on Monday. One analyst has rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus price target of $101.61.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.